Skip to content

Supplier News

Watson cleared to market lidocaine patch

Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for its lidocaine topical patch 5%. The company said Thursday that the product is the generic equivalent of Endo Pharmaceuticals Inc.’s Lidoderm.

SymphonyIRI appoints retail solutions president

SymphonyIRI Group Inc. has named Beverly Grant as president of retail solutions. The consumer packaged goods (CPG), retail and health care market research firm said Tuesday that Grant, who previously held various positions in a 26-year career at Procter & Gamble Co.

Energizer, Wahl reach settlement

Energizer Holdings Inc. has settled patent infringement litigation against the Wahl Clipper Corp. Energizer said Tuesday that its lawsuit, filed in U.S. District Court for the Northern District of Illinois in April, claimed that primary lithium batteries supplied by Great Power Battery Co. Ltd.

CCA names new board member

CCA Industries Inc. has appointed Jonathan Rothschild as a director on its board. The company said is Rothschild is president and chief executive officer of Arterio Inc., which is in the vitamins and supplements business, and a director of Immucell Inc., a biotechnology company.

Sanofi ships Sklice head lice lotion

Sanofi Pasteur has released Sklice Lotion, a topical treatment of head lice, to U.S. pharmacies. The Sanofi vaccines division said Monday that Sklice (ivermectin 0.5%), for use on the hair and scalp, is indicated for treating head lice infestations in patients age 6 months and older.

Prasco to release Xopenex authorized generic

Prasco Laboratories has entered an agreement with Sunovion Pharmaceuticals Inc. to distribute an authorized generic version of Xopenex Inhalation Solution, a respiratory medication. Prasco said Monday that its Xopenex authorized generic product will be sold in 1.25 mg/3 mL, 0.63 mg/3 mL and 0.